BrisboisTD, et al.: Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer: An argument for the application of sensory science. J Palliat Care, 2006; 22:111–114.
2.
YavuzsenT, et al.: Components of the anorexia-cachexia syndrome: Gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer, 2009; 17:1531–1541.
3.
BernhardsonBM, TishelmanC, RutqvistLE: Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer, 2008; 16:275–283.
4.
SteinbachS, et al.: Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol, 2009; 27:1899–1905.
5.
BaharvandM, et al.: Taste alteration and impact on quality of life after head and neck radiotherapy. J Oral Pathol Med, 2013; 42:106–112.
6.
HongJH, et al.: Taste and odor abnormalities in cancer patients. J Support Oncol, 2009; 7:58–65.
7.
AllisTJ, LeopoldDA: Smell and taste disorders. Facial Plast Surg Clin North Am, 2012; 20:93–111.
8.
FarkT, et al.: Characteristics of taste disorders. Eur Arch Otorhinolaryngol, 2013; 270:1855–1860.
9.
BrisboisTD, et al.: Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. J Pain Symptom Manage, 2011; 41:673–683.
10.
BernhardsonBM, et al.: Reframing eating during chemotherapy in cancer patients with chemosensory alterations. Eur J Oncol Nurs, 2012; 16:483–490.
11.
SpeckRM, et al.: Taste alteration in breast cancer patients treated with taxane chemotherapy: Experience, effect, and coping strategies. Support Care Cancer, 2013; 21:549–555.
12.
WismerWV: Assessing alterations in taste and their impact on cancer care. Curr Opin Support Palliat Care, 2008; 2:282–287.
13.
RavascoP, et al.: Dietary counseling improves patient outcomes: A prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol, 2005; 23:1431–1438.
14.
HummelT, LandisBN, HuttenbrinkKB: Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2011; 10:4.
15.
HeckmannSM, et al.: Gabapentin has little or no effect in the treatment of burning mouth syndrome: Results of an open-label pilot study. Eur J Neurol, 2006; 13:e6–e7.
16.
StrasserF, et al.: Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: A randomized, placebo-controlled, double-blind study. Oncologist, 2008; 13:337–346.
17.
BuntzelJ, et al.: Radiochemotherapy with amifostine cytoprotection for head and neck cancer. Support Care Cancer, 1998; 6:155–160.
18.
SpanembergJC, et al.: Burning mouth syndrome: Update. Oral Health Dent Manag, 2014; 13:418–424.
19.
CarboneM, et al.: Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: A double-blind, randomized, placebo-controlled study. Eur J Pain, 2009; 13:492–496.
20.
Lopez-JornetP, Camacho-AlonsoF, Leon-EspinosaS: Efficacy of alpha lipoic acid in burning mouth syndrome: A randomized, placebo-treatment study. J Oral Rehabil, 2009; 36:52–57.
21.
StrasserF, LuftnerD, PossingerK, et al.; Cannabis in Cachexia Study Group: Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol, 2006; 24:3394–3400.
22.
NajafizadeN, et al.: Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial. J Res Med Sci, 2013; 18:123–126.
23.
HalyardMY, et al.: Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys, 2007; 67:1318–1322.
24.
MatsonA, et al.: Zinc supplementation at conventional doses does not improve the disturbance of taste perception in hemodialysis patients. J Ren Nutr, 2003; 13:224–228.
